Document:

EX-4.4

Exhibit 4.4

ALIMERA SCIENCES, INC.

SECOND AMENDED AND RESTATED STOCK SALE AGREEMENT

     THIS SECOND AMENDED AND RESTATED STOCK SALE AGREEMENT (the “Agreement”) is made this
17th day of March, 2008, by and among Alimera Sciences, Inc., a Delaware corporation
(the “Company”), the holders of the Company’s Common Stock, par value $0.01 per share (the
“Common Stock”), listed on the Schedule of Common Holders attached as Exhibit A hereto (the
“Common Holders”), the holders of the Company’s Series A Preferred Stock, par value $0.01
per share (the “Series A Stock”), listed on Exhibit B attached hereto (the “Series A
Investors”), the holders of the company’s Series B Preferred Stock, par value $0.01 share (the
“Series B Stock”), listed on Exhibit C hereto (the “Series B Investors”) and the
holders of the Company’s Series C Preferred Stock, par value $0.01 per share (the “Series C
Stock”, and together with the Series A Stock and Series B Stock, the “Preferred
Stock”), listed on Exhibit D attached hereto (the “Series C Investors” and, together
with the Series A Investors and the Series B Investors, the “Investors”). The Common
Holders, the Series A Investors, the Series B Investors, and the Series C Investors, collectively
shall be referred to herein as the “Stockholders.”

RECITALS

     WHEREAS, each Common Holder is the holder of outstanding shares of Common Stock;

     WHEREAS, the Company proposes to obtain equity financing from the Series C Investors pursuant
to that certain Series C Preferred Stock Purchase Agreement, dated as of the date hereof (the
“Series C Purchase Agreement”), by and among the Company and the Series C Investors, which
financing the Company, the Common Holders, the Series A Investors and the Series B Investors
believe to be in the best interests of the Company and its stockholders;

     WHEREAS, the Investors are parties to an Amended and Restated Stock Sale Agreement dated
November 22, 2005 by and among the Company, the Series A Investors, the Series B Investors and the
Common Holders (the “Prior Agreement”);

     WHEREAS, the parties to such Prior Agreement desire to amend and restate the Prior Agreement
and to accept the rights and covenants hereof in lieu of their rights and covenants under the Prior
Agreement; and

     WHEREAS, the Series C Investors have requested, as a condition to entering into the Series C
Purchase Agreement, that the Common Holders, the Series A Investors and the Series B Investors
enter into this Agreement, and the Common Holders, the Series A Investors and the Series B
Investors, as an inducement to the Series C Investors to enter into the Series C Purchase
Agreement, are willing to enter into this Agreement.

 

 

AGREEMENT

     NOW, THEREFORE, in consideration of the premises, and the mutual covenants and terms hereof,
the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows.

     1. Prohibited Transfers. Except for a Permitted Transfer (as defined herein), the
Common Holders shall not sell, assign, transfer, pledge, hypothecate, mortgage or dispose of, by
gift or otherwise, or in any way encumber, whether voluntarily or by operation of law (a
“Transfer”), all or any part of the Shares (as hereinafter defined) owned by them during
the term of this Agreement other than in compliance with the terms of this Agreement. For purposes
of this Agreement, the term “Shares” shall mean and include all shares of capital stock of
the Company owned or held at any time by a Common Holder or by any transferee thereof. Shares
owned or held by a Common Holder shall include shares of capital stock which the Common Holder has
the right to acquire upon the conversion or exercise of all securities convertible into or
exercisable for Common Stock of the Company, and any reference to a Transfer of Shares shall
include a Transfer of such convertible securities.

     2. Rights of First Refusal and Co-Sale.

          2.1 Right of First Refusal.

               (a) If at any time any Common Holder (the “Seller”) desires (or is required) to
Transfer any Shares to a third party other than the Company (the “Buyer”), such Seller
shall provide notice of such proposed sale to the Company and the Investors in accordance with
Section 2.3 hereof, and the Company shall have a period of 15 days after its receipt of such notice
(such date of receipt, the “Notice Date”) to elect to purchase all of the Shares proposed
to be sold or transferred by the Seller (the “Offered Shares”) at the same price per share
and on the same terms and conditions as involved in such sale or disposition. The Company shall
promptly deliver a copy of each such notice to the members of its Board of Directors.

               (b) If the Company does not elect to purchase all of the Offered Shares pursuant to Section
2.1(a), then for a period of 30 days from the Notice Date, each Investor (or any transferee of the
Investor) shall have the right to require, as a condition to such sale or transfer, that the Seller
sell to such Investor (or such transferee) at the same price per share and on the same terms and
conditions as involved in such sale or disposition that percentage (subject to overallotment
rights) of the Offered Shares expressed by a fraction, the numerator of which is the number of
shares of Common Stock (less any shares of Ineligible Stock (as defined below)) and Preferred Stock
(on an as-converted to Common Stock basis) then held by the Investor (or such transferee), and the
denominator of which is the aggregate number of all shares of Common Stock (less all shares of
Ineligible Stock) and Preferred Stock then held by all the Investors and transferees of the
Investors, if any, on an as-converted to Common Stock basis. Notwithstanding the foregoing, any
such Investor may, at the time it accepts the offer, subscribe to purchase any or all securities
offered (“Oversubscription Securities”) which may be available as a result of the
rejection, or partial rejection, of the offer by other Investors. All Oversubscription Securities
shall be offered, on a pro rata basis, to those Investors electing to purchase Oversubscription
Securities. The sale of Oversubscription Securities shall continue pursuant to the process set

2

 

forth in the immediately preceding sentence until all of the Offered Shares have been
purchased by the Investors or until no Investor desires to purchase any remaining Offered Shares.

               (c) Notwithstanding the foregoing, in the event that the Company and the Investors do not
purchase all of the Offered Shares, then the Seller may sell all of the Offered Shares to the
Buyer, except as provided in Section 2.2.

          2.2 Right of Co-Sale. If the Seller desires (or is required) to Transfer any Shares
to a Buyer, each Investor (or any transferee of the Investor) shall have the right, in lieu of
exercise of its right of first refusal as provided in Section 2.1(b) above, to require, as a
condition to such Transfer, that the Buyer purchase from the Investor (or such transferee), that
percentage of the Offered Shares not otherwise purchased by the Company or the Investors pursuant
to Section 2.1 above that is expressed by a fraction, the numerator of which is the number of
shares of Preferred Stock (on an as-converted into Common Stock basis) and Common Stock (less any
shares of Ineligible Stock) then held by the Investor (or such transferee), and the denominator of
which is the number of shares of Preferred Stock (on an as-converted into Common Stock basis) and
Common Stock (less all shares of Ineligible Stock) held by all the Investors and the Seller.

          2.3 Notice. In the event the Seller proposes to undertake a Transfer of Shares, it
shall give the Company, Investors and transferees of the Investors, if any, written notice of its
intention, describing the price and general terms upon which the Seller proposes to transfer
Shares. The Company shall have 15 days, and the Investors and transferees of the Investors, if
any, shall have 30 days from the Notice Date to either (a) exercise the right of first refusal
under Section 2.1 for the price and upon the general terms specified in the notice by giving
written notice to the Seller and stating therein the quantity of Shares to be purchased, or (b) if
applicable, exercise the right of co-sale under Section 2.2 hereof by giving written notice to the
Seller and stating therein the quantity of Shares to be included in the Transfer. The closing of
the Transfer of Shares covered by any such exercise of rights by the Company or Investors pursuant
to Section 2.1 or 2.2 shall occur on the date, if any, set forth in the Seller’s notice pursuant to
this Section 2.3 or on such other date as the parties may agree, provided that if no date
is so specified, the closing shall occur on the date 45 days after the date of the Seller’s notice
pursuant to this Section 2.3, or on such other date as the parties may agree. At the closing, the
selling parties shall deliver certificates representing the securities to be sold, duly endorsed
for Transfer and accompanied by all requisite transfer taxes, if any, and such securities to be
transferred shall be free and clear of any liens, claims or encumbrances (other than restrictions
imposed pursuant to this Agreement and applicable federal and state securities laws), and the
purchasing parties shall deliver payment of the purchase price therefor on the terms described in
the Seller’s written notice pursuant to this Section 2.3.

          2.4 Transfer of Rights. The rights contained in this Section 2 may be assigned or
otherwise conveyed to transferees or assignees of the Investors’ shares of Preferred Stock and
Common Stock issued upon conversion of such Preferred Stock, which transferees or assignees will be
considered “Investors” for purposes hereof.

          2.5 Transfers Constituting Liquidating Event. In the event of any Transfer or
proposed Transfer that, together with all other transfers of shares, or rights to acquire shares,
that are part of the same transaction or series of related transactions, constitutes or would
constitute a

3

 

Liquidating Event for purposes of the Company’s Restated Certificate of Incorporation (the
“Certificate of Incorporation”), then such Transfer may not take place unless and until,
prior to the consummation of such Transfer the Investors shall have been paid in full the amounts
to which they are entitled upon such Liquidating Event under the Certificate of Incorporation.

     3. Permitted Transfers. The rights and transfer restrictions set forth in Section 2
hereof shall not apply to: (a) any Transfer of Shares by gift or bequest or through inheritance
to, or for the benefit of, any spouse, ancestor, sibling or descendant of such individual Common
Holder or any other person approved by a majority of the Board of Directors (including, for this
purpose, a majority of the directors elected by the holders of Preferred Stock pursuant to Article
V, Subsection D.3 of the Company’s Certificate of Incorporation); (b) any Transfer of Shares by an
individual Common Holder to a trust for the benefit of any spouse, ancestor, sibling or descendant
of such Common Holder; (c) a Transfer of Shares by a Common Holder to the Company; and (d) any
Transfer of Shares by a Common Holder that is an entity to such entity’s stockholders, members,
partners or other equity holders (in each case set forth in (a) through (d) above, a “Permitted
Transfer”). Any such Permitted Transfer shall be subject to the terms and provisions of this
Agreement, and the transferee receiving Shares (other than where the Company is the transferee)
shall be bound by the terms and conditions of this Agreement to the same extent as the person
making such Transfer. Each transferee in a Permitted Transfer (other than where the Company is the
transferee) after the date of this Agreement shall execute and deliver to the Company a counterpart
of this Agreement as a condition to the effectiveness of such Permitted Transfer.

     4. Termination. The rights set forth in this Agreement shall terminate upon the
effective date of the closing of an underwritten public offering pursuant to an effective
registration statement under the 1933 Act, covering the offer and sale of Common Stock of the
Company to the public where the Company receives proceeds of $50,000,000 or more (net of
underwriters discounts and commissions), and the price per share to the public is not less than
$5.93, subject to adjustment in the event of any stock dividend, stock split, combination or other
similar recapitalization.

     5. Specific Performance. The rights of the parties under this Agreement are unique
and, accordingly, the parties shall, in addition to such other remedies as may be available to any
of them at law or in equity, have the right to enforce their rights hereunder by actions for
specific performance to the extent permitted by law.

     6. Legend. Each certificate held by or issued to the Common Holders, whether now
outstanding or subsequently issued, shall be surrendered to the Company for endorsement or be
endorsed by the Company prior to its issuance with substantially the following legend.

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A STOCK SALE AGREEMENT
AMONG THE HOLDER OF THESE SECURITIES AND CERTAIN OTHER HOLDERS OF THE ISSUER’S
SECURITIES. BY ACCEPTING ANY INTEREST IN SUCH SECURITIES, THE PERSON ACCEPTING SUCH
INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL OF THE PROVISIONS
OF SUCH AGREEMENT. COPIES OF SUCH AGREEMENT MAY BE

4

 

OBTAINED UPON WRITTEN REQUEST BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE
SECRETARY OF THE CORPORATION AT THE PRINCIPAL EXECUTIVE OFFICES OF THE CORPORATION.

     Nothing in this Agreement should be construed as a modification or amendment of any
restrictions on transfer under applicable federal or state securities laws.

     7. Additional Common Holders. The Company shall cause each person or entity hereafter
becoming a holder of shares of the Company’s Common Stock to become a party to this Agreement as a
“Common Holder,” subject to all applicable terms and provisions hereof, by having such
holder execute a signature page hereto and amending Exhibit A pursuant to Section 9.3 below.

     8. Amendment and Restatement of Prior Agreement. The Prior Agreement is hereby
amended in its entirety and restated herein. Such amendment and restatement is effective upon the
execution of this Agreement by the Company, the holders of at least two-thirds (2/3) of the
outstanding Common Stock as of the date of this Agreement held by the Common Holders providing
services to the Company as an officer, employee or consultant, and the holders of at least a
majority of the outstanding Preferred Stock as of the date of this Agreement. Upon such execution,
all provisions of, rights granted and covenants made in the Prior Agreement are hereby waived,
released and superseded in their entirety and shall have no further force or effect.

     9. General Provisions.

          9.1 Governing Law. This Agreement shall be governed by the laws of the State of
Delaware without regard to choice of law provisions.

          9.2 Entire Agreement. This Agreement constitutes the entire agreement among the
parties with respect to the subject matter hereof and supersedes all prior agreements and
understandings between them or any of them as to such subject matter. This Agreement shall be
binding upon and shall inure to the benefit of the parties hereto and their heirs, executors, legal
representative, successors and permitted transferees, except as may be expressly provided otherwise
herein.

          9.3 Amendments and Waivers. Except as otherwise expressly provided herein, this
Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance, either retroactively or prospectively and either for a
specified period of time or indefinitely) only upon the written consent of: (a) the Company, (b)
the holders of at least a majority of the then outstanding Common Stock held by the Common Holders
then providing services to the Company as an officer, employee or consultant, and (c) the holders
of at least a majority of the then outstanding Preferred Stock held by the Investors.
Notwithstanding anything to the contrary in this Section 9.3, the Company shall be entitled to in
accordance with Section 7, include additional holders of its Common Stock as parties to this
Agreement, and to treat such holders as “Common Holders” hereunder by having each such
holder execute a signature page hereto, amending Exhibit A attached hereto and providing such
amended Exhibit A to the other parties to this Agreement.

5

 

          9.4 Severability. In the case any one or more of the provisions contained in this
Agreement shall for any reason be held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not affect any other provision of this Agreement
and such invalid, illegal and unenforceable provision shall be reformed and construed so that it
will be valid, legal, and enforceable to the maximum extent permitted by law.

          9.5 Successors and Assigns. The provisions hereof shall inure to the benefit of, and
be binding upon, the parties hereto and their respective successors, assigns, heirs, executors and
administrators and other legal representatives.

          9.6 Ownership. Each Common Holder represents and warrants that he, she or it is the
sole legal and beneficial owner of those Shares he or she currently holds subject to this Agreement
and that no other person has any interest (other than a community property interest) in such
shares.

          9.7 Notice. Any notice required or permitted under this Agreement shall be given in
writing and shall be deemed effectively given and received: (a) upon personal delivery to the party
to be notified; (b) upon delivery by confirmed facsimile or electronic transmission if received by
the recipient before 5:00 p.m. local time on a business day, and if not, then the next business
day; (c) if to a U.S. resident, five (5) days after deposit with the United States Post Office, by
registered or certified mail, postage prepaid; or (d) if to a U.S. resident, one (1) business day
after deposit with a nationally recognized overnight courier service (or if to a non-U.S. resident,
two (2) business days after deposit with an internationally recognized overnight courier service,
specifying international priority delivery), and addressed to the parties at the addresses of the
parties set forth at the end of this Agreement or such other address as a party may request by
notifying the other in writing.

          9.8 Attorneys’ Fees. In the event that any suit or action is instituted under or in
relation to this Agreement, including without limitation to enforce any provision in this
Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party
all fees, costs and expenses of enforcing any right of such prevailing party under or with respect
to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and
accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

          9.9 Delays or Omissions. Any party’s failure to enforce any provision or provisions
of this Agreement shall not in any way be construed as a waiver of any such provision or
provisions, nor prevent that party thereafter from enforcing each and every other provision of this
Agreement. The rights granted to the parties herein are cumulative and not alternative.

          9.10 Intent. The Stockholders agree to execute upon request any further documents or
instruments necessary or desirable to carry out the purposes or intent of this Agreement.

          9.11 Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be enforceable against the parties actually executing such counterparts, and all of
which together shall constitute one instrument.

6

 

[Remainder of page intentionally left blank]

7

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	COMPANY:
	 
	 	 	 	 
	 	 	ALIMERA SCIENCES, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	INTERSOUTH PARTNERS V, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Intersouth Associates V, L.P.,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	INTERSOUTH AFFILIATES V, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Intersouth Associates V, LLC,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	INTERSOUTH PARTNERS VI, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Intersouth Associates VI, LLC,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	INTERSOUTH PARTNERS VII, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Intersouth Associates VII, L.P.,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	VENROCK PARTNERS, L.P.
	 	 	by its General Partner,
Venrock Partners Management, LLC
	 
	 	 	 	 
	 	 	VENROCK ASSOCIATES IV, L.P.
	 	 	by its General Partner, Venrock Management IV, LLC
	 
	 	 	 	 
	 	 	VENROCK ENTREPRENEURS FUND IV, L.P.
	 	 	by its General Partner, VEF Management IV, LLC
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:
	 	 Member

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	BAVP, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	BA Venture Partners VI, LLC,
	 

	 	 	 	its general partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	 	 	Managing Director

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	POLARIS VENTURE PARTNERS IV, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Polaris Venture Management Co. IV, L.L.C.,
	 

	 	 	 	its General Partner
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	POLARIS VENTURE
PARTNERS ENTREPRENEURS’ FUND IV, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Polaris Venture Management Co. IV, L.L.C.,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	DOMAIN PARTNERS VI, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	One Palmer Square Associates VI, L.L.C.,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	DP VI ASSOCIATES, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	One Palmer Square Associates VI, L.L.C.,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	G&H PARTNERS
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	INVESTOR/COMMON HOLDER:
	 
	 	 	 	 
	 	 	 
	 	 	Dr. Calvin Roberts

Signature Page to

Second Amended and Restated Stock Sale Agreement

 

 

     IN WITNESS WHEREOF, this Second Amended and Restated Stock Sale Agreement has been duly
executed and delivered by the parties as of the date first above written.

	 	 	 	 	 
	 	 	COMMON STOCKHOLDERS:
	 
	 	 	 	 
	 	 	 
	 	 	C. Daniel Myers
	 
	 	 	 	 
	 	 	 
	 	 	David Holland
	 
	 	 	 	 
	 	 	 
	 	 	Alisa Hudzina
	 
	 	 	 	 
	 	 	 
	 	 	Susan Caballa
	 
	 	 	 	 
	 	 	 
	 	 	David Eitel

Signature Page to

Second Amended and Restated Stock Sale AgreementEX-10.1

Exhibit 10.1

ALIMERA SCIENCES, INC.

INDEMNIFICATION AGREEMENT

     This Indemnification Agreement (“Agreement”) is made as of                      by and between
Alimera Sciences, Inc. a Delaware corporation (the “Company”), and [                      ]
(“Indemnitee”).

RECITALS

     WHEREAS, highly competent persons have become more reluctant to serve publicly held
corporations as directors or in other capacities unless they are provided with adequate protection
through insurance or adequate indemnification against inordinate risks of claims and actions
against them arising out of their service to and activities on behalf of the corporation;

     WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in
order to attract and retain qualified individuals, the Company will attempt to maintain on an
ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and
its subsidiaries from certain liabilities. The Restated Certificate of Incorporation of the Company
(the “Charter”) authorizes indemnification of the officers and directors of the Company and
the By-laws of the Company (the “By-laws”) require such indemnification. Indemnitee may
also be entitled to indemnification pursuant to the General Corporation Law of the State of
Delaware (“DGCL”). The Charter, By-laws and DGCL provide that the indemnification
provisions set forth therein are not exclusive, and thereby contemplate that contracts may be
entered into between the Company and members of the board of directors, officers and other persons
with respect to indemnification;

     WHEREAS, the uncertainties relating to such insurance and to indemnification have increased
the difficulty of attracting and retaining such persons;

     WHEREAS, the Board has determined that the increased difficulty in attracting and retaining
such persons is detrimental to the best interests of the Company’s stockholders and that the
Company should act to assure such persons that there will be increased certainty of such protection
in the future;

     WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate
itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent
permitted by applicable law so that they will serve or continue to serve the Company free from
undue concern that they will not be so indemnified;

     WHEREAS, this Agreement is a supplement to and in furtherance of the indemnification provided
in the Charter and By-laws and any resolutions adopted pursuant thereto, and shall not be deemed a
substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

     WHEREAS, Indemnitee does not regard the protection available under the Charter, By-laws and
DGCL and insurance as being adequate in the present circumstances, and in

 

 

consideration of serving as a director desires to be assured of adequate protection, and the
Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to
serve and to take on additional service for or on behalf of the Company on the condition that
Indemnitee be so indemnified; and

     NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the
Company and Indemnitee do hereby covenant and agree as follows:

     Section 1. Services to the Company. Indemnitee agrees to serve as a ___
[director, officer, etc.] of the Company. Indemnitee may at any time and for any reason resign from
such position (subject to any other contractual obligation or any obligation imposed by operation
of law), in which event the Company shall have no obligation under this Agreement to continue
Indemnitee in such position. This Agreement shall not be deemed an employment contract between the
Company (or any of its subsidiaries or any Enterprise) and Indemnitee. The foregoing
notwithstanding, this Agreement shall continue in force after Indemnitee’s services to the Company
have ceased.

     Section 2. Definitions

     As used in this Agreement:

          (a) “Corporate Status” describes the status of a person who is or was a director,
officer, employee or agent of the Company or of any other corporation, partnership or joint
venture, trust, employee benefit plan or other enterprise which such person is or was serving at
the request of the Company.

          (b) “Enterprise” shall mean the Company and any other corporation, partnership, joint
venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at
the request of the Company as a director, officer, employee, agent or fiduciary.

          (c) “Expenses” shall include all reasonable attorneys’ fees, retainers, court costs,
transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and
binding costs, telephone charges, postage, delivery service fees, and all other disbursements or
expenses of the types customarily incurred in connection with prosecuting, defending, preparing to
prosecute or defend, investigating, being or preparing to be a witness in, or otherwise
participating in, a Proceeding. Expenses also shall include Expenses incurred in connection with
any appeal resulting from any Proceeding, including without limitation the premium, security for,
and other costs relating to any cost bond, supersedes bond, or other appeal bond or its equivalent.
Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of
judgments or fines against Indemnitee.

          (d) “Independent Counsel” means a law firm, or a partner (or, if applicable, member)
of such a law firm, that is experienced in matters of corporation law and neither presently is, nor
in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter
material to either such party (other than with respect to matters concerning the Indemnitee under
this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any
other party to the Proceeding giving rise to a claim for

- 2 -

 

indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall
not include any person who, under the applicable standards of professional conduct then prevailing,
would have a conflict of interest in representing either the Company or Indemnitee in an action to
determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees
and expenses of the Independent Counsel referred to above and to fully indemnify such counsel
against any and all Expenses, claims, liabilities and damages arising out of or relating to this
Agreement or its engagement pursuant hereto.

          (e) The term “Proceeding” shall include any threatened, pending or completed action,
suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative
hearing or any other actual, threatened or completed proceeding, whether brought in the right of
the Company or otherwise and whether of a civil, criminal, administrative or investigative nature,
in which Indemnitee was, is or will be involved as a party or otherwise by reason of Indemnitee’s
Corporate Status, by reason of any action taken by him or of any action on his part while acting in
such capacity, or by reason of the fact that he is or was serving at the request of the Company as
a director, officer, employee or agent of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise, in each case whether or not serving in such capacity at
the time any liability or expense is incurred for which indemnification, reimbursement, or
advancement of expenses can be provided under this Agreement; except one initiated by Indemnitee to
enforce his rights under this Agreement.

     Section 3. Indemnity in Third-Party Proceedings. The Company shall indemnify
Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened
to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the
right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee
shall be indemnified against all Expenses, judgments, fines and amounts paid in settlement actually
and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any
claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably
believed to be in or not opposed to the best interests of the Company and, in the case of a
criminal proceeding, had no reasonable cause to believe that his conduct was unlawful. Indemnitee
shall not enter into any settlement in connection with a Proceeding without 10 days prior notice to
the Company.

     Section 4. Indemnity in Proceedings by or in the Right of the Company. The Company
shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or
is threatened to be made, a party to or a participant in any Proceeding by or in the right of the
Company to procure a judgment in its favor. Pursuant to this Section 4, Indemnitee shall be
indemnified against all Expenses actually and reasonably incurred by him or on his behalf in
connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good
faith and in a manner he reasonably believed to be in or not opposed to the best interests of the
Company. No indemnification for Expenses shall be made under this Section 4 in respect of any
claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be
liable to the Company, unless and only to the extent that the Delaware Court of Chancery (the
“Delaware Court”) or any court in which the Proceeding was brought shall determine upon
application that, despite the adjudication of liability but in view of all the

- 3 -

 

circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification for
such expenses as the Delaware Court or such other court shall deem proper.

     Section 5. Indemnification for Expenses of a Party Who is Wholly or Partly Successful.
Notwithstanding any other provisions of this Agreement, to the extent that Indemnitee is a party
to or a participant in and is successful, on the merits or otherwise, in any Proceeding or in
defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify
Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or
otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the
Company shall indemnify Indemnitee against (a) all Expenses actually and reasonably incurred by him
or on his behalf in connection with each successfully resolved claim, issue or matter and (b) any
claim, issue or matter related to any such successfully resolved claim, issue or matter. For
purposes of this Section and without limitation, the termination of any claim, issue or matter in
such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful
result as to such claim, issue or matter.

     Section 6. Indemnification For Expenses of a Witness. Notwithstanding any other
provision of this Agreement, to the extent that Indemnitee is, by reason of his Corporate Status, a
witness in any Proceeding to which Indemnitee is not a party, he shall be indemnified against all
Expenses actually and reasonably incurred by him or on his behalf in connection therewith.

     Section 7. Additional Indemnification.

          (a) Notwithstanding any limitation in Sections 3, 4, or 5, the Company shall indemnify
Indemnitee to the fullest extent permitted by law if Indemnitee is a party to or threatened to be
made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure
a judgment in its favor) against all Expenses, judgments, fines and amounts paid in settlement
actually and reasonably incurred by Indemnitee in connection with the Proceeding.

          (b) For purposes of Section 7(a), the meaning of the phrase “to the fullest extent permitted
by law” shall include, but not be limited to:

               (i) to the fullest extent permitted by the provision of the DGCL that authorizes or
contemplates additional indemnification by agreement, or the corresponding provision of any
amendment to or replacement of the DGCL, and

               (ii) to the fullest extent authorized or permitted by any amendments to or replacements of the
DGCL adopted after the date of this Agreement that increase the extent to which a corporation may
indemnify its officers and directors.

     Section 8. Exclusions. Notwithstanding any provision in this Agreement to the
contrary, the Company shall not be obligated under this Agreement to make any indemnity in
connection with any claim made against Indemnitee:

          (a) for an accounting of profits made from the purchase and sale (or sale and purchase) by
Indemnitee of securities of the Company within the meaning of Section 16(b) of the

- 4 -

 

Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or
common law;

          (b) for claims initiated or brought by Indemnitee, except (i) with respect to actions or
proceedings brought to establish or enforce a right to receive Expenses or indemnification under
this Agreement or any other agreement or insurance policy or under the Charter or Bylaws now or
hereafter in effect relating to indemnification, (ii) if the Board has approved the initiation or
bringing of such claim, or (iii) as otherwise required under Delaware law;

          (c) for which payment has actually been made to or on behalf of Indemnitee under any insurance
policy or other indemnity provision, except with respect to any excess beyond the amount paid under
any insurance policy or other indemnity provision; or

          (d) for which payment is prohibited by applicable law.

     Section 9. Advances of Expenses. The Company shall advance, to the extent not
prohibited by law, the Expenses incurred by Indemnitee in connection with any Proceeding, and such
advancement shall be made within 30 days after the receipt by the Company of a statement or
statements requesting such advances (which shall include invoices received by Indemnitee in
connection with such Expenses but, in the case of invoices in connection with legal services, any
references to legal work performed or to expenditures made that would cause Indemnitee to waive any
privilege accorded by applicable law shall not be included with the invoice) from time to time,
whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and
interest free. Advances shall be made without regard to Indemnitee’s ability to repay the expenses
and without regard to Indemnitee’s ultimate entitlement to indemnification under the other
provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred
pursuing an action to enforce this right of advancement, including Expenses incurred preparing and
forwarding statements to the Company to support the advances claimed. The Indemnitee shall qualify
for advances upon the execution and delivery to the Company of this Agreement which shall
constitute an undertaking providing that the Indemnitee undertakes to the fullest extent permitted
by law to repay the advance if and to the extent that it is ultimately determined by final judicial
decision from which there is no further right to appeal that Indemnitee is not entitled to be
indemnified by the Company. This Section 9 shall not apply to any claim made by Indemnitee for
which indemnity is excluded pursuant to Section 8. The right to advances under this paragraph
shall in all events continue until final disposition of any Proceeding, including any appeal
therein.

     Section 10. Procedure for Notification and Defense of Claim.

          (a) To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a
written request therefor.

- 5 -

 

          (b) The Company will be entitled to participate in the Proceeding at its own expense.

     Section 11. Procedure Upon Application for Indemnification.

          (a) Upon written request by Indemnitee for indemnification pursuant to Section 10(a), a
determination, if required by applicable law, with respect to Indemnitee’s entitlement thereto
shall be made in the specific case by Independent Counsel chosen in accordance Section 11(b) below
and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee
shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the
Independent Counsel making such determination with respect to Indemnitee’s entitlement to
indemnification, including providing to such counsel upon reasonable advance request any
documentation or information which is not privileged or otherwise protected from disclosure and
which is reasonably available to Indemnitee and reasonably necessary to such determination. Any
costs or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so
cooperating with the Independent Counsel shall be borne by the Company (irrespective of the
determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies
and agrees to hold Indemnitee harmless therefrom.

          (b) The Independent Counsel shall be selected by Company or its designee. The Indemnitee may,
within 10 days after written notice of such selection, deliver to the Company a written objection
to such selection; provided, however, that such objection may be asserted only on
the ground that the Independent Counsel so selected does not meet the requirements of “Independent
Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with
particularity the factual basis of such assertion. Absent a proper and timely objection, the person
so selected shall act as Independent Counsel. If such written objection is so made and
substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and
until such objection is withdrawn or a court has determined that such objection is without merit.
If, within 20 days after the later of submission by Indemnitee of a written request for
indemnification pursuant to Section 10(a) hereof, and the final disposition of the Proceeding
including any appeal therein, no Independent Counsel shall have been selected and not objected to,
the Company may petition a court of competent jurisdiction for resolution of any objection which
shall have been made by the Imdemnitee to the selection of Independent Counsel and/or for the
appointment as Independent Counsel of a person selected by the court or by such other person as the
court shall designate, and the person with respect to whom all objections are so resolved or the
person so appointed shall act as Independent Counsel under Section 11(a) hereof. Upon the due
commencement of any judicial proceeding or arbitration pursuant to Section 13(a) of this Agreement,
Independent Counsel shall be discharged and relieved of any further responsibility in such capacity
(subject to the applicable standards of professional conduct then prevailing).

     Section 12. Presumptions and Effect of Certain Proceedings.

          (a) In making a determination with respect to entitlement to indemnification hereunder, the
Independent Counsel making such determination shall presume that Indemnitee is entitled to
indemnification under this Agreement if Indemnitee has submitted a request for

- 6 -

 

indemnification in accordance with Section 10(a) of this Agreement, and the Company shall have
the burden of proof to overcome that presumption in connection with the making by the Independent
Counsel of any determination contrary to that presumption. Neither the failure of the Company or of
Independent Counsel to have made a determination prior to the commencement of any action pursuant
to this Agreement that indemnification is proper in the circumstances because Indemnitee has met
the applicable standard of conduct, nor an actual determination by the Company or by Independent
Counsel that Indemnitee has not met such applicable standard of conduct, shall be a defense to the
action or create a presumption that Indemnitee has not met the applicable standard of conduct.

          (b) The termination of any Proceeding or of any claim, issue or matter therein, by judgment,
order, settlement or conviction, or upon a plea of nolo contendere or its
equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee
did not act in good faith and in a manner which he reasonably believed to be in or not opposed to
the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had
reasonable cause to believe that his conduct was unlawful.

          (c) For purposes of any determination of good faith, Indemnitee shall be deemed to have acted
in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise,
including financial statements, or on information supplied to Indemnitee by the officers of the
Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or
the Board or counsel selected by any committee of the Board or on information or records given or
reports made to the Enterprise by an independent certified public accountant or by an appraiser,
investment banker or other expert selected with the reasonable care by the Company or the Board or
any committee of the Board. The provisions of this Section 12(c) shall not be deemed to be
exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to
have met the applicable standard of conduct set forth in this Agreement.

          (d) The knowledge and/or actions, or failure to act, of any director, officer, agent or
employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right
to indemnification under this Agreement.

     Section 13. Remedies of Indemnitee.

          (a) Subject to Section 13(e), in the event that (i) a determination is made pursuant to
Section 11 of this Agreement that Indemnitee is not entitled to indemnification under this
Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 9 of this Agreement,
(iii) no determination of entitlement to indemnification shall have been made pursuant to Section
11(a) of this Agreement within 90 days after receipt by the Company of the request for
indemnification, (iv) payment of indemnification is not made pursuant to Section 5 or 6 or the last
sentence of Section 11(a) of this Agreement within ten (10) days after receipt by the Company of a
written request therefor, or (v) payment of indemnification pursuant to Section 3, 4 or 7 of this
Agreement is not made within ten (10) days after a determination has been made that Indemnitee is
entitled to indemnification, Indemnitee shall be entitled to an adjudication by a court of his
entitlement to such indemnification or advancement of Expenses. Alternatively, Indemnitee, at his
option, may seek an award in arbitration to be conducted by a single arbitrator

- 7 -

 

pursuant to the Commercial Arbitration Rules of the American Arbitration Association.
Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within
180 days following the date on which Indemnitee first has the right to commence such proceeding
pursuant to this Section 13(a); provided, however, that the foregoing clause shall
not apply in respect of a proceeding brought by Indemnitee to enforce his rights under Section 5 of
this Agreement. The Company shall not oppose Indemnitee’s right to seek any such adjudication or
award in arbitration.

          (b) In the event that a determination shall have been made pursuant to Section 11(a) of this
Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or
arbitration commenced pursuant to this Section 13 shall be conducted in all respects as a de novo
trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that
adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section
13 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or
advancement of Expenses, as the case may be.

          (c) If a determination shall have been made pursuant to Section 11(a) of this Agreement that
Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any
judicial proceeding or arbitration commenced pursuant to this Section 13, absent (i) a misstatement
by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
statement not materially misleading, in connection with the request for indemnification, or (ii) a
prohibition of such indemnification under applicable law.

          (d) The Company shall be precluded from asserting in any judicial proceeding or arbitration
commenced pursuant to this Section 13 that the procedures and presumptions of this Agreement are
not valid, binding and enforceable and shall stipulate in any such court or before any such
arbitrator that the Company is bound by all the provisions of this Agreement. The Company shall
indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within
ten (10) days after receipt by the Company of a written request therefor) advance, to the extent
not prohibited by law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection
with any action brought by Indemnitee for indemnification or advance of Expenses from the Company
under this Agreement or under any directors’ and officers’ liability insurance policies maintained
by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such
indemnification, advancement of Expenses or insurance recovery, as the case may be.

          (e) Notwithstanding anything in this Agreement to the contrary, no determination as to
entitlement to indemnification under this Agreement shall be required to be made prior to the final
disposition of the Proceeding. For the avoidance of doubt, the parties agree that this subsection
(e) shall not affect the Company’s obligation to advance Expenses under Section 9 or Section 13(d)
as incurred and on a timely basis.

     Section 14. Non-exclusivity; Survival of Rights; Insurance; Subrogation.

          (a) The rights of indemnification and to receive advancement of Expenses as provided by this
Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be
entitled under applicable law, the Charter, the Company’s

- 8 -

 

By-laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No
amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or
restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by
such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the
extent that a change in Delaware law, whether by statute or judicial decision, permits greater
indemnification or advancement of Expenses than would be afforded currently under the Charter,
By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by
this Agreement the greater benefits so afforded by such change. No right or remedy herein
conferred is intended to be exclusive of any other right or remedy, and every other right and
remedy shall be cumulative and in addition to every other right and remedy given hereunder or now
or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or
remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any
other right or remedy.

          (b) To the extent that the Company maintains an insurance policy or policies providing
liability insurance for directors, officers, employees, or agents of the Company or of any other
Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their
terms to the maximum extent of the coverage available for any such director, officer, employee or
agent under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant
to the terms hereof, the Company has director and officer liability insurance in effect, the
Company shall give prompt notice of the commencement of such proceeding to the insurers in
accordance with the procedures set forth in the respective policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee,
all amounts payable as a result of such proceeding in accordance with the terms of such policies.

          (c) In the event of any payment under this Agreement, the Company shall be subrogated to the
extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers
required and take all action necessary to secure such rights, including execution of such documents
as are necessary to enable the Company to bring suit to enforce such rights.

          (d) The Company shall not be liable under this Agreement to make any payment of amounts
otherwise indemnifiable (or for which advancement is provided hereunder) hereunder if and to the
extent that Indemnitee has otherwise actually received such payment under any insurance policy,
contract, agreement or otherwise.

     Section 15. Duration of Agreement. This Agreement shall continue until and terminate
upon the later of: (a) 10 years after the date that Indemnitee shall have ceased to serve as a
director of the Company or (b) 1 year after the final termination of any Proceeding then pending in
respect of which Indemnitee is granted rights of indemnification or advancement of Expenses
hereunder and of any proceeding commenced by Indemnitee pursuant to Section 13 of this Agreement
relating thereto. This Agreement shall be binding upon the Company and its successors and assigns
and shall inure to the benefit of Indemnitee and his heirs, executors and administrators. The
Company shall require and cause any successor (whether direct or indirect by purchase, merger,
consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or
assets of the Company, by written agreement in form and substance

- 9 -

 

satisfactory to the Indemnitee, expressly to assume and agree to perform this Agreement in the
same manner and to the same extent that the Company would be required to perform if no such
succession had taken place.

     Section 16. Severability. If any provision or provisions of this Agreement shall be
held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality
and enforceability of the remaining provisions of this Agreement (including without limitation,
each portion of any Section of this Agreement containing any such provision held to be invalid,
illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any
way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by
law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform
to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to
the fullest extent possible, the provisions of this Agreement (including, without limitation, each
portion of any Section of this Agreement containing any such provision held to be invalid, illegal
or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to
give effect to the intent manifested thereby.

     Section 17. Enforcement.

          (a) The Company expressly confirms and agrees that it has entered into this Agreement and
assumed the obligations imposed on it hereby in order to induce Indemnitee to serve or continue to
serve as a director of the Company, and the Company acknowledges that Indemnitee is relying upon
this Agreement in serving as a director of the Company.

          (b) This Agreement constitutes the entire agreement between the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements and understandings, oral, written and
implied, between the parties hereto with respect to the subject matter hereof; provided,
however, that this Agreement is a supplement to and in furtherance of the Charter of the
Company, the By-laws of the Company and applicable law, and shall not be deemed a substitute
therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.

     Section 18. Modification and Waiver. No supplement, modification or amendment of this
Agreement shall be binding unless executed in writing by the parties thereto. No waiver of any of
the provisions of this Agreement shall be deemed or shall constitute a waiver of any other
provisions of this Agreement nor shall any waiver constitute a continuing waiver.

     Section 19. Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in
writing upon being served with any summons, citation, subpoena, complaint, indictment, information
or other document relating to any Proceeding or matter which may be subject to indemnification or
advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall
not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement
or otherwise.

     Section 20. Notices. All notices, requests, demands and other communications under
this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by
hand and receipted for by the party to whom said notice or other communication shall have been
directed, (b) mailed by certified or registered mail with postage prepaid, on the third

- 10 -

 

business day after the date on which it is so mailed, (c) mailed by reputable overnight
courier and receipted for by the party to whom said notice or other communication shall have been
directed or (d) sent by facsimile transmission, with receipt of oral confirmation that such
transmission has been received:

          (a) If to Indemnitee, at such address as Indemnitee shall provide to the Company.

          (b) If to the Company to:

	 	 	 
	 

	 	Alimera Sciences, Inc.
	 

	 	6120 Windward Parkway, Suite 290
	 

	 	Alpharetta, GA 30005
	 

	 	Attention:                                         

or to any other address as may have been furnished to Indemnitee by the Company.

     Section 21. Contribution.

          (a) To the fullest extent permissible under applicable law, if the indemnification provided
for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu
of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for
judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for
Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in
such proportion as is deemed fair and reasonable in light of all of the circumstances of such
Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as
a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the
relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in
connection with such event(s) and/or transaction(s).

          (b) The Company shall not enter into any settlement of any Proceeding in which the Company is
jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement
provides for a full and final release of all claims asserted against Indemnitee.

          (c) The Company hereby agrees to fully indemnify and hold harmless Indemnitee from any
claims for contribution which may be brought by officers, directors or employees of the Company
other than Indemnitee who may be jointly liable with Indemnitee.

     Section 22. Applicable Law and Consent to Jurisdiction. This Agreement and the legal
relations among the parties shall be governed by, and construed and enforced in accordance with,
the laws of the State of Delaware, without regard to its conflict of laws rules. Except with
respect to any arbitration commenced by Indemnitee pursuant to Section 13(a) of this Agreement, the
Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or
proceeding arising out of or in connection with this Agreement shall be brought only in the
Delaware Court, and not in any other state or federal court in the United States of America or any
court in any other country, (ii) consent to submit to the exclusive jurisdiction of

- 11 -

 

the Delaware Court for purposes of any action or proceeding arising out of or in connection
with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service of
process in the State of Delaware, CT Corporation as its agent in the State of Delaware as such
party’s agent for acceptance of legal process in connection with any such action or proceeding
against such party with the same legal force and validity as if served upon such party personally
within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or
proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that
any such action or proceeding brought in the Delaware Court has been brought in an improper or
inconvenient forum.

     Section 23. Identical Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall for all purposes be deemed to be an original but all of which
together shall constitute one and the same Agreement. Only one such counterpart signed by the party
against whom enforceability is sought needs to be produced to evidence the existence of this
Agreement.

     Section 24. Termination of Prior Agreement. Upon execution of this Agreement by the
Company and Indemnitee, such parties hereto acknowledge that any and all indemnification agreements
previously entered into by and between Indemnitee and the Company, if any, which provide for the
indemnification of Indemnittee pursuant to the terms and conditions thereof are hereby amended,
restated and superseded in their entirety by this Agreement.

     Section 25. Miscellaneous. The headings of the paragraphs of this Agreement are
inserted for convenience only and shall not be deemed to constitute part of this Agreement or to
affect the construction thereof.

- 12 -

 

     IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year
first above written.

	 	 	 	 	 
	 	ALIMERA SCIENCES, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	INDEMNITEE:

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	 	 
	 

- 13 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00144-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00144-of-00352.parquet"}]]